financial statements for the 6 months ended June 30, 2019 as follows: Overview of Operating Performance Company and its subsidiaries had revenue classified by product category consist revenue from the

Global Green Chemicals Public Company Limited Management Discussion and Analysis For the Operating Results of 1Q2020 P a g e | 2 - Management Discussion and Analysis 1Q2020 - Executive Summary In

June 2020 To : The President The Stock Exchange of Thailand Bangkok Chain Hospital Public Company Limited (the “Company”) would like to report the operating results for the second quarter ended 30 June

financial statements for the year ended December 31, 2019 as follows: Overview of Operating Performance Company and its subsidiaries had revenue classified by product category consist revenue from the

of Thailand 1. Analysis of Operating Results and Financial Position for the Company and its subsidiary 1.1 Analysis of Operating Results for the Company and its subsidiary for the 3-month period ended

the 3rd quarter financial statements as of November 30, 2020 which were reviewed by Deloitte Touche Tohmatsu Jaiyos Audit Company Limited. The operating performance is summarized are as follows

Discussion & Analysis Q1/2022 Operating Highlights in Q1/2022 Q1/21 Q1/22 Change +/(-) (THB million) %YoY Operating Revenue 179 198 11% Gross Profit 105 120 14% EBITDA 57 58 2% Net Profit (Loss) for the

2.03 27% Core EBITDA/t (US$/t)) 107 100 94 14% 97 86 13% Net Operating Debt to Equity 0.84 0.80 0.99 0.84 0.99 Note: (1) Consolidated financials are based upon elimination of intra-company (or intra

analysis should be read in conjunction with our financial statements and accompanying notes, as well as our selected operating data, included elsewhere in this Offering Circular. Our financial statements

3 VIII. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 5 IX. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 6 X. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 7 XI. INTERESTS OF EXPERTS AND COUNSEL 8